LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 4.36 | 84.90 | 591 | 322 | 1.8322 | 1.7389 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 4.36 | 84.90 | 713 | 322 | 2.2104 | 2.0192 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 6.06 | 84.90 | 3 | 365 | 0.0082 | -0.7955 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 6.06 | 84.90 | 672 | 365 | 1.8388 | 1.6708 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 6.06 | 84.90 | 777 | 365 | 2.1261 | 1.8615 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 7.77 | 84.90 | 3 | 411 | 0.0073 | -0.7698 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 7.77 | 84.90 | 758 | 411 | 1.8432 | 1.6164 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 7.77 | 84.90 | 868 | 411 | 2.1107 | 1.7769 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 9.47 | 84.90 | 2 | 447 | 0.0045 | -0.7905 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 9.47 | 84.90 | 832 | 447 | 1.8595 | 1.5905 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 9.47 | 84.90 | 1 | 447 | 0.0022 | -0.8431 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 9.47 | 84.90 | 929 | 447 | 2.0763 | 1.7124 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 11.18 | 84.90 | 4 | 492 | 0.0081 | -0.7002 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 11.18 | 84.90 | 884 | 492 | 1.7954 | 1.5192 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 11.18 | 84.90 | 1 | 492 | 0.0020 | -0.8265 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 11.18 | 84.90 | 1011 | 492 | 2.0534 | 1.6561 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 12.88 | 84.90 | 7 | 531 | 0.0132 | -0.6107 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 12.88 | 84.90 | 955 | 531 | 1.7985 | 1.4969 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 12.88 | 84.90 | 2 | 531 | 0.0038 | -0.7576 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 12.88 | 84.90 | 1073 | 531 | 2.0207 | 1.6094 | MN20160318_Q02 | J17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 14.58 | 84.90 | 8 | 663 | 0.0121 | -0.5490 | MN20160318_Q02 | E17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.056667 | 14.58 | 84.90 | 1010 | 663 | 1.5224 | 1.3045 | MN20160318_Q02 | E17 |